Copertina

Differential effects of ketamine enantiomers on EEG parameters including the gamma‐delta shift phenomenon

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Szabolcs Koncz, Dóra Pothorszki, Noémi Papp, Donát Pál, György Bagdy
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Reconsidering the gamma–delta shift as a biomarker of antidepressant effects of ketamine enantiomers
di: Kenji Hashimoto
Pubblicazione: (2026)

Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects
di: Marije E. Otto, et al.
Pubblicazione: (2026)

Contribution of peripheral and central delta opioid receptors in the relief of migraine‐like headache in female and male rats
di: Manon Dussol, et al.
Pubblicazione: (2025)

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain
di: Siddhesh S. Sabnis, et al.
Pubblicazione: (2024)

The pancreatic signal of GLP‐1 receptor agonists: A biliary phenomenon rather than direct toxicity
di: Andro Koren, et al.
Pubblicazione: (2026)

Gβγ subunit activation of K V 7 and BK Ca channels underlies calcitonin gene‐related peptide vasorelaxation in myogenic rat coronary resistance arteries
di: Lucy A. Donovan, et al.
Pubblicazione: (2026)

Extracellular ATP inhibits excitatory synaptic input on parvalbumin positive interneurons and attenuates gamma oscillations via P2X4 receptors
di: Florian Wildner, et al.
Pubblicazione: (2024)

Progress on the development of Class A GPCR‐biased ligands
di: Paula Morales, et al.
Pubblicazione: (2024)

The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19
di: Henrietta Papp, et al.
Pubblicazione: (2024)

Differential modulation of BK channels by simvastatin: Critical role of the auxiliary β 4 subunit
di: Gangjing Li, et al.
Pubblicazione: (2026)

Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
di: Francisco Alejandro Lagunas‐Rangel, et al.
Pubblicazione: (2024)

Assessment of individual disciplines before and after a shift to an active‐learning and integrated curriculum
di: Ivy Click, et al.
Pubblicazione: (2025)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
di: H. Ongun Onaran, et al.
Pubblicazione: (2024)

Bioavailability of flumequine and diclofenac in mice exposed to a metal‐drug chemical cocktail. Evaluation of the protective role of selenium.
di: Noemí Aranda‐Merino, et al.
Pubblicazione: (2024)

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome
di: Maren Hermanns‐Clausen, et al.
Pubblicazione: (2026)

Dual effects of mefenamic acid on the IKs molecular complex
di: Magnus Chan, et al.
Pubblicazione: (2024)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
di: Prajakta Pramod Biyani, et al.
Pubblicazione: (2025)

Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
di: Ryan J. Rakoczy, et al.
Pubblicazione: (2024)

Anti‐inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis
di: Fynn Gurski, et al.
Pubblicazione: (2024)

Have plastic culture models prevented the discovery of effective cancer therapeutics?
di: Kevin M. Tharp
Pubblicazione: (2024)

Network medicine and systems pharmacology approaches to predicting adverse drug effects
di: Alessio Funari, et al.
Pubblicazione: (2024)

Circadian time‐dependent effects of experimental colitis on theophylline disposition and toxicity
di: Yi Yang, et al.
Pubblicazione: (2024)

RETRACTION: Ligand‐Induced Differentiation of Glucocorticoid Receptor (GR) Trans‐Repression and Transactivation: Preferential Targeting of NF‐κB and Lack of I‐κB Involvement
Pubblicazione: (2025)

Evaluation of the antihypertensive and antihyperlipidaemic effects of a pyrimidine derivative in preventing cardiometabolic risk
di: Baskar Aswinanand, et al.
Pubblicazione: (2026)

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis
di: Fanchao Zhou, et al.
Pubblicazione: (2025)

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
di: Elisa Kiselev, et al.
Pubblicazione: (2025)

Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes—current status
di: Kjetil Wessel Andressen, et al.
Pubblicazione: (2025)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
di: Dávid Nagy, et al.
Pubblicazione: (2025)

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats
di: Srinivas Kamath, et al.
Pubblicazione: (2024)

Anti‐inflammatory effects of physical stimuli: The central role of networks in shaping the future of pharmacological research
di: Veronica Paparozzi, et al.
Pubblicazione: (2025)

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors
di: Jessica L. Meades, et al.
Pubblicazione: (2025)

Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first‐line antihypertensive drugs
di: Cristina González‐Correa, et al.
Pubblicazione: (2024)

Polarized effects of adenosine on blood–brain barrier integrity: Tightening from the luminal and opening from the abluminal side
di: András Harazin, et al.
Pubblicazione: (2026)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
di: Jae‐Hun Ahn, et al.
Pubblicazione: (2025)

Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning
di: Dongxue Yan, et al.
Pubblicazione: (2025)

Correction to “Deletion of AMPKα1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adioponectin release”
Pubblicazione: (2025)

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways
di: Paola Rogliani, et al.
Pubblicazione: (2025)

Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy
di: Elisa Landucci, et al.
Pubblicazione: (2024)

The mitochondrial calcium uniporter inhibitor Ru265 increases neuronal excitability and reduces neurotransmission via off‐target effects
di: Peng Xu, et al.
Pubblicazione: (2024)

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss
di: Anna Pisani, et al.
Pubblicazione: (2024)